Skip to main content
TScan Therapeutics, Inc. logo

TScan Therapeutics, Inc. — Investor Relations & Filings

Ticker · TCRX ISIN · US89854M1018 US Professional, scientific and technical activities
Open in API
Filings indexed 310 across all filing types
Latest filing 2021-09-09 Director's Dealing
Country US United States of America
Listing US TCRX

About TScan Therapeutics, Inc.

https://www.tscan.com

TScan Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of cancer. The company's approach is centered on discovering highly effective, naturally occurring TCRs and using them to genetically reprogram T cells. This strategy aims to harness the power of the human immune system to deliver safe and effective immunotherapies to patients.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2021-09-09 English
FORM 3 SUBMISSION
Director's Dealing
2021-09-09 English
FORM 4 SUBMISSION
Director's Dealing
2021-09-09 English
FORM 4 SUBMISSION
Director's Dealing
2021-08-31 English
10-Q
Interim / Quarterly Report Q2 2021
2021-08-19 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 19, 2021, reporting the issuance of a press release announcing financial results for the quarter ended June 30, 2021. The text explicitly states that the press release is furnished as an exhibit and that the information is not "filed" for purposes of Section 18 of the Exchange Act, indicating this is a current report announcing financial results rather than the full earnings release document itself. The document length is 3699 characters, which is relatively short and mainly serves as an announcement of the earnings release. According to the classification rules, initial announcements of quarterly financial results (key highlights only) are classified as Earnings Release (ER). Since this is a Form 8-K announcing the earnings release and including the press release as an exhibit, it fits best under Earnings Release (ER).
2021-08-19 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.